MA

Mohamed Abubacker Aysha

Active Director Director DIN 10941702
DIN 10941702 First appointment Feb 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohamed Abubacker Aysha

Data last updated:

Mohamed Abubacker Aysha is a Director at Azaan Life Science Private Limited (since 2025). The company operates in Paper.

DIN 10941702
Primary Designation Director
Industry Paper
First Appointment 26 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Azaan Life Science Private Limited U21002KA2025PTC198672
Director26 Feb 20252025Active

Board colleagues of Mohamed Abubacker Aysha

Directorship timeline

Open interactive timeline →
Azaan Life Science Private Limited
Premium access

Shareholding and investment profile for Mohamed Abubacker Aysha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohamed Abubacker Aysha

Mohamed Abubacker Aysha currently holds 1 directorship: Azaan Life Science Private Limited (Director, since 26 Feb 2025).

Mohamed Abubacker Aysha was first appointed on 26 Feb 2025 as Director at Azaan Life Science Private Limited.

The current boards of Mohamed Abubacker Aysha's companies include Aysha Nasreen (Azaan Life Science Private Limited), Azharudeen Mohammed (Azaan Life Science Private Limited), Zeenath Nasreen (Azaan Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available